ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

November 25, 2005

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

ACS California Division Offers Fellowships For Clinical Research

June 14, 1996

Letters to the Editor: Love on Mammography; Freireich, Holland On Bernard Fisher

April 15, 1994

Survival After Liver Transplant Called Excellent In Study

November 28, 2003

Dismissed Leukemia Drug Helps CLL, Clinical Trials Find

December 26, 2008